These mechanisms, particularly the activation of MAPK signaling and modulation of immune pathways, support the hypothesis that NPSR1-AS1 may also contribute to interferon gamma pathway regulation, a key target of 1,25(OH)2D3-mediated immune modulation in squamous cell carcinoma. Here, IFNG is linked to squamous cell carcinoma.